Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Mazereeuw

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|August 26, 2016
Dr Mazereeuw and Colleagues ReplyGraham Mazereeuw, Krista L Lanctôt, Nathan Herrmann
Pain|June 16, 2018
Depression in chronic pain: might opioids be responsible?Graham Mazereeuw, Mark D Sullivan, David N Juurlink
The Journal of Clinical Psychiatry|December 10, 2015
Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trialsJordana O'Regan, Krista L Lanctôt, Graham Mazereeuw, et al.
Biological Psychiatry|July 19, 2014
Reply to: Serum zinc and the risk of depression in men: observations from a 20-year follow-up studyWalter Swardfager, Nathan Herrmann, Graham Mazereeuw, et al.
Neurobiology of Aging|February 7, 2012
Effects of ω-3 fatty acids on cognitive performance: a meta-analysisGraham Mazereeuw, Krista L Lanctôt, Sarah A Chau, et al.
Neuropsychiatric Disease and Treatment|October 23, 2015
A meta-analysis of lipid peroxidation markers in major depressionGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Biological Psychiatry|June 29, 2013
Zinc in depression: a meta-analysisWalter Swardfager, Nathan Herrmann, Graham Mazereeuw, et al.
CMAJ Open|November 10, 2017
Availability of naloxone in Canadian pharmacies:a population-based surveyAlex M Cressman, Graham Mazereeuw, Qi Guan, et al.
American Heart Journal|April 24, 2012
Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysisWalter Swardfager, Nathan Herrmann, Stephen Cornish, et al.
Brain, Behavior, and Immunity|December 25, 2015
Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patientsGraham Mazereeuw, Nathan Herrmann, David W L Ma, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|August 26, 2016
Dr Mazereeuw and Colleagues ReplyGraham Mazereeuw, Krista L Lanctôt, Nathan Herrmann
Pain|June 16, 2018
Depression in chronic pain: might opioids be responsible?Graham Mazereeuw, Mark D Sullivan, David N Juurlink
The Journal of Clinical Psychiatry|December 10, 2015
Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trialsJordana O'Regan, Krista L Lanctôt, Graham Mazereeuw, et al.
Biological Psychiatry|July 19, 2014
Reply to: Serum zinc and the risk of depression in men: observations from a 20-year follow-up studyWalter Swardfager, Nathan Herrmann, Graham Mazereeuw, et al.
Neurobiology of Aging|February 7, 2012
Effects of ω-3 fatty acids on cognitive performance: a meta-analysisGraham Mazereeuw, Krista L Lanctôt, Sarah A Chau, et al.
Neuropsychiatric Disease and Treatment|October 23, 2015
A meta-analysis of lipid peroxidation markers in major depressionGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
Biological Psychiatry|June 29, 2013
Zinc in depression: a meta-analysisWalter Swardfager, Nathan Herrmann, Graham Mazereeuw, et al.
CMAJ Open|November 10, 2017
Availability of naloxone in Canadian pharmacies:a population-based surveyAlex M Cressman, Graham Mazereeuw, Qi Guan, et al.
American Heart Journal|April 24, 2012
Exercise intervention and inflammatory markers in coronary artery disease: a meta-analysisWalter Swardfager, Nathan Herrmann, Stephen Cornish, et al.
Brain, Behavior, and Immunity|December 25, 2015
Omega-3/omega-6 fatty acid ratios in different phospholipid classes and depressive symptoms in coronary artery disease patientsGraham Mazereeuw, Nathan Herrmann, David W L Ma, et al.
Pageof 2